# The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism.

> **NCT06756737** · — · NOT_YET_RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Primary Aldosteronism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06756737
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06756737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06756737, "The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06756737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*